. .. Remerciements, 101. Fièvre et syndrome inflammatoire en médecine interne

.. .. Sur-le-plan-physiopathologique, 122.2 La PCT dans les services de médecine interne

.. .. La,

.. .. Sur-le-plan-pratique,

.. .. Dimension-Éthique-de-l'étude,

.. .. But-de-l'étude,

.. .. Objectifs-de-l'étude,

.. .. Etiologies,

. , Valeur de la PCT en fonction de l'étiologie retrouvée

. , Analyse des résultats en excluant les patients « étiologie inconnue » et analyse de sensibilité

. , PCT et infection bactérienne certaine/ probable

P. .. Courbes-roc-de-la,

P. .. Caractéristiques-opératoires-de-la,

. , Résultats retrouvés pour un seuil de PCT à 0

C. .. Concernant-la,

P. ?. Valeur-pronostique-de-la,

. .. Discussion,

. La-pct-est-elle-un-marqueur-diagnostique-d, infection bactérienne devant une fièvre et/ou un syndrome inflammatoire en médecine interne ?

. Quel and P. ?. De, Population de l'étude, critères étudiés

P. La and ?. .. ,

D. 'un-point-de-vue-Économique and .. .. ,

M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud et al., High serum procalcitonin concentrations in patients with sepsis and infection, Lancet Lond Engl. 27 févr, vol.341, issue.8844, pp.515-523, 1993.

M. Christ-crain and B. Müller, Procalcitonin in bacterial infections-hype, hope, more or less, Swiss Med Wkly. 6 août, vol.135, pp.451-60, 2005.

M. D. De-kruif, L. C. Lemaire, I. A. Giebelen, J. Struck, N. G. Morgenthaler et al., The influence of corticosteroids on the release of novel biomarkers in human endotoxemia, Intensive Care Med. mars, vol.34, issue.3, pp.518-540, 2008.

S. Jeong, Y. Park, Y. Cho, and H. Kim, Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture, Clin Chim Acta Int J Clin Chem, vol.413, pp.1731-1737, 2012.

I. Delèvaux, M. André, M. Colombier, E. Albuisson, F. Meylheuc et al., Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?, Ann Rheum Dis. avr, vol.62, issue.4, pp.337-377, 2003.

I. Delevaux, M. André, R. J. Begue, M. Colombier, J. C. Piette et al., La procalcitonine permet-elle de différentier les infections bactériennesdes maladies inflammatoires ?, Rev Médecine Interne. déc, vol.22, 2001.

F. Ghiringhelli, V. Lemaire, S. Berthier, and B. Lorcerie, Intérêt du dosage de la procalcitonine pour discriminer les maladies infectieusesdes autres causes de syndromes inflammatoires, Rev Médecine Interne. déc, vol.22, pp.440-441, 2001.

V. Queyrel, O. Lefebvre, P. Y. Hatron, U. Michon-pasturel, A. L. Fauchais et al., La procalcitonine chez les patients fébriles hospitalisés en médecine interne. Étude prospective de janvier 1999 à janvier, Rev Médecine Interne. déc, vol.22, pp.439-440, 2001.

R. Ruiz-esteban, P. R. Sarabia, E. G. Delgado, C. B. Aguado, J. A. Cuervo-arango et al., Procalcitonin and C-reactive protein levels as diagnostic tools in febrile patients admitted to a General Internal Medicine ward, Clin Biochem. janv, vol.45, issue.1-2, pp.22-27, 2012.

C. Lin, S. Hsieh, L. Keng, H. Lee, H. Chang et al., Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases, PloS One, vol.11, issue.4, p.153938, 2016.

S. T. Choi and J. S. Song, Serum Procalcitonin as a Useful Serologic Marker for Differential Diagnosis between Acute Gouty Attack and Bacterial Infection, Yonsei Med J. sept, vol.57, issue.5, pp.1139-1183, 2016.

M. Christ-crain, D. Jaccard-stolz, R. Bingisser, M. M. Gencay, P. R. Huber et al., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet Lond Engl. 21 févr, vol.363, issue.9409, pp.600-607, 2004.

N. Johansson, M. Kalin, C. Backman-johansson, A. Larsson, K. Nilsson et al., Procalcitonin levels in community-acquired pneumonia-correlation with aetiology and severity, Scand J Infect Dis, vol.46, issue.11, pp.787-91, 2014.

M. Ip, T. H. Rainer, N. Lee, C. Chan, S. Chau et al., Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections, Diagn Microbiol Infect Dis, vol.59, issue.2, pp.131-137, 2007.

C. Wacker, A. Prkno, F. M. Brunkhorst, and P. Schlattmann, Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis, Lancet Infect Dis. mai, vol.13, issue.5, pp.426-461, 2013.

S. Y. Guo, Y. Zhou, Q. F. Hu, J. Yao, and H. Wang, Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis, Am J Med Sci. juin, vol.349, issue.6, pp.499-504, 2015.

M. Pr?cha, H. I. Zazula, R. Dubská, L. Kavka, B. Dostál et al.,

, Vnitr? ní Lékar? ství, juill, vol.49, issue.7, pp.541-548, 2003.

M. T. Sandri, R. Passerini, M. E. Leon, F. A. Peccatori, L. Zorzino et al., Procalcitonin as a useful marker of infection in hemato-oncological patients with fever, Anticancer Res, vol.28, issue.5B, pp.3061-3066, 2008.

Y. Fu, H. Jiang, L. Li, J. Chen, J. Zhang et al., Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia

Z. Hui and J. , Exp Hematol Chin Assoc Pathophysiol. oct, vol.21, issue.5, pp.1296-300, 2013.

C. Chenevier-gobeaux, E. Trabattoni, Y. Elfassy, C. Picard, S. Guérin et al., Decisional procalcitonin thresholds are not adapted to elderly patients admitted to the emergency room, Biomark Biochem Indic Expo Response Susceptibility Chem. août, vol.17, issue.5, pp.477-81, 2012.

S. Lee, R. Chan, J. Wu, H. Chen, S. Chang et al., Diagnostic value of procalcitonin for bacterial infection in elderly patients-a systemic review and meta-analysis

, Int J Clin Pract. déc, vol.67, issue.12, pp.1350-1357, 2013.

S. Manzano, B. Bailey, J. Girodias, A. Galetto-lacour, J. Cousineau et al., Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial, Am J Emerg Med. juill, vol.28, issue.6, pp.647-53, 2010.

F. Lopez, A. , L. Cubells, C. , G. García et al., Spanish Society of Pediatric Emergencies. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker, Pediatr Infect Dis J. oct, vol.22, issue.10, pp.895-903, 2003.

C. W. Hicks, R. S. Engineer, J. L. Benoit, S. Dasarathy, R. H. Christenson et al., Procalcitonin as a biomarker for early sepsis in the emergency department, Eur J Emerg Med Off J Eur Soc Emerg Med. avr, vol.21, issue.2, pp.112-119, 2014.

G. A. Alba, Q. A. Truong, H. K. Gaggin, P. U. Gandhi, D. Berardinis et al., Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea, Am J Med. 11 juill, 2015.

T. Sitter, M. Schmidt, S. Schneider, and H. Schiffl, Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin, J Nephrol. juin, vol.15, issue.3, pp.297-301, 2002.

A. A. Dahaba, P. H. Rehak, and W. F. List, Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis, Intensive Care Med. avr, vol.29, issue.4, pp.579-83, 2003.

X. Lu, X. , Y. Zhu, and Y. , Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc-Eur Ren Assoc. janv, vol.28, issue.1, pp.122-131, 2013.

A. Flahault, M. Cadilhac, and G. Thomas, Sample size calculation should be performed for design accuracy in diagnostic test studies, J Clin Epidemiol. août, vol.58, issue.8, pp.859-62, 2005.

M. Patout, M. Salaün, V. Brunel, S. Bota, B. Cauliez et al., Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers, Clin Biochem. déc, vol.47, issue.18, pp.263-270, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01120476

D. Keramidaris, N. Koronakis, E. E. Lagoudianakis, A. Pappas, I. Koukoutsis et al., Procalcitonin in patients with colorectal cancer, J BUON Off J Balk Union Oncol. sept, vol.18, issue.3, pp.623-631, 2013.

M. Ozmen, E. Oktay, E. F. Tarhan, O. Aslan, U. Oflazoglu et al., Serum procalcitonin levels in patients with ankylosing spondylitis, Int J Rheum Dis. mai, vol.19, issue.5, pp.500-505, 2016.

J. Zhang, J. Liu, L. Long, Q. Zhou, J. Cheng et al.,

, Zhonghua Yi Xue Za Zhi. 18 août, vol.95, issue.31, pp.2556-2565, 2015.

X. Liu, D. F. Wang, Y. Fang, W. F. Ye, S. Liu et al., Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia, Leuk Lymphoma. janv, vol.56, issue.1, pp.85-91, 2015.

S. Hangai, Y. Nannya, and M. Kurokawa, Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseases, Leuk Lymphoma. avr, vol.56, issue.4, pp.910-914, 2015.

N. E. Hammond, A. Corley, and J. F. Fraser, The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients, Anaesth Intensive Care. mars, vol.39, issue.2, pp.238-279, 2011.

E. Grace and R. M. Turner, Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy, Clin Infect Dis Off Publ Infect Dis Soc Am. 15 déc, vol.59, issue.12, pp.1761-1768, 2014.

I. Delèvaux, M. André, F. Meylheuc, R. J. Bègue, and O. Aumaître, Intérêt du dosage de la procalcitonine en médecine interne, Rev Médecine Interne. déc, vol.21, p.517, 2000.